The European Commission has approved Sanofi’s Teizeild as the first disease-modifying therapy in the EU to delay the onset of stage 3 type 1 diabetes in adults and children with stage 2 T1D. Supported ...
(IN BRIEF) Thiess has secured a new six-year contract with MACH Energy to provide expanded full mining services at the Mount Pleasant Operation in New South Wales through to 2031. The agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback